Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 503

1.

Participating in core outcome set development via Delphi surveys: qualitative interviews provide pointers to inform guidance.

Biggane AM, Williamson PR, Ravaud P, Young B.

BMJ Open. 2019 Nov 14;9(11):e032338. doi: 10.1136/bmjopen-2019-032338.

PMID:
31727660
2.

Potential of Stratified Medicine for High Blood Pressure Management: A Modeling Study Using NHANES Survey Data.

Porcher R, Tran VT, Blacher J, Ravaud P.

Hypertension. 2019 Dec;74(6):1420-1427. doi: 10.1161/HYPERTENSIONAHA.119.13749. Epub 2019 Nov 4.

PMID:
31679427
3.

Extensions of the probabilistic ranking metrics of competing treatments in network meta-analysis to reflect clinically important relative differences on many outcomes.

Mavridis D, Porcher R, Nikolakopoulou A, Salanti G, Ravaud P.

Biom J. 2019 Oct 29. doi: 10.1002/bimj.201900026. [Epub ahead of print]

PMID:
31661561
4.

Is My Patient Overwhelmed?: Determining Thresholds for Acceptable Burden of Treatment Using Data From the ComPaRe e-Cohort.

Tran VT, Montori VM, Ravaud P.

Mayo Clin Proc. 2019 Oct 7. pii: S0025-6196(19)30770-0. doi: 10.1016/j.mayocp.2019.09.004. [Epub ahead of print]

PMID:
31619365
5.

Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort.

Mariette X, Perrodeau E, Verner C, Struillou X, Picard N, Schaeverbeke T, Constantin A, Ravaud P, Bouchard P.

Rheumatology (Oxford). 2019 Sep 3. pii: kez368. doi: 10.1093/rheumatology/kez368. [Epub ahead of print]

PMID:
31504982
6.

Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis.

Virone A, Bastard JP, Fellahi S, Capeau J, Rouanet S, Sibilia J, Ravaud P, Berenbaum F, Gottenberg JE, Sellam J.

RMD Open. 2019 Jul 21;5(2):e000897. doi: 10.1136/rmdopen-2019-000897. eCollection 2019.

7.

Correction to: Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit.

Boutron I, Haneef R, Yavchitz A, Baron G, Novack J, Oransky I, Schwitzer G, Ravaud P.

BMC Med. 2019 Jul 27;17(1):147. doi: 10.1186/s12916-019-1388-4.

8.

Patients' views of wearable devices and AI in healthcare: findings from the ComPaRe e-cohort.

Tran VT, Riveros C, Ravaud P.

NPJ Digit Med. 2019 Jun 14;2:53. doi: 10.1038/s41746-019-0132-y. eCollection 2019.

9.

Overcoming Barriers to Mobilizing Collective Intelligence in Research: Qualitative Study of Researchers With Experience of Collective Intelligence.

Nguyen VT, Young B, Ravaud P, Naidoo N, Benchoufi M, Boutron I.

J Med Internet Res. 2019 Jul 2;21(7):e13792. doi: 10.2196/13792.

10.

Front-of-Pack Labeling and the Nutritional Quality of Students' Food Purchases: A 3-Arm Randomized Controlled Trial.

Egnell M, Boutron I, Péneau S, Ducrot P, Touvier M, Galan P, Buscail C, Porcher R, Ravaud P, Hercberg S, Kesse-Guyot E, Julia C.

Am J Public Health. 2019 Aug;109(8):1122-1129. doi: 10.2105/AJPH.2019.305115. Epub 2019 Jun 20.

PMID:
31219721
11.

Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitis.

Montante A, Le Bras A, Pagnoux C, Perrodeau E, Ravaud P, Terrier B, Guillevin L, Durand-Zaleski I; French Vasculitis Study Group.

Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):137-143. Epub 2019 May 21.

12.

Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit.

Boutron I, Haneef R, Yavchitz A, Baron G, Novack J, Oransky I, Schwitzer G, Ravaud P.

BMC Med. 2019 Jun 4;17(1):105. doi: 10.1186/s12916-019-1330-9. Erratum in: BMC Med. 2019 Jul 27;17(1):147.

13.

Consolidated Standards of Reporting Trials (CONSORT) extensions covered most types of randomized controlled trials, but the potential workload for authors was high.

Ghosn L, Boutron I, Ravaud P.

J Clin Epidemiol. 2019 Sep;113:168-175. doi: 10.1016/j.jclinepi.2019.05.030. Epub 2019 May 30. Review.

PMID:
31153976
14.

Changes in total sperm count after gastric bypass and sleeve gastrectomy: the BARIASPERM prospective study.

Carette C, Levy R, Eustache F, Baron G, Coupaye M, Msika S, Barrat C, Cohen R, Catheline JM, Brugnon F, Slim K, Barsamian C, Chevallier JM, Bretault M, Bouillot JL, Antignac JP, Rives-Lange C, Ravaud P, Czernichow S.

Surg Obes Relat Dis. 2019 Aug;15(8):1271-1279. doi: 10.1016/j.soard.2019.04.019. Epub 2019 Apr 25.

PMID:
31147284
15.

Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.

Puéchal X, Pagnoux C, Baron G, Lifermann F, Geffray L, Quémeneur T, Saraux JL, Wislez M, Cottin V, Ruivard M, Limal N, Aouba A, Bonnotte B, Néel A, Agard C, Cohen P, Terrier B, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group investigators.

Rheumatology (Oxford). 2019 May 5. pii: kez139. doi: 10.1093/rheumatology/kez139. [Epub ahead of print]

PMID:
31056661
16.

Patients' perspective on how to improve the care of people with chronic conditions in France: a citizen science study within the ComPaRe e-cohort.

Tran VT, Riveros C, Péan C, Czarnobroda A, Ravaud P.

BMJ Qual Saf. 2019 Nov;28(11):875-886. doi: 10.1136/bmjqs-2018-008593. Epub 2019 Apr 23.

17.

Power behind the throne: A clinical trial simulation study evaluating the impact of controllable design factors on the power of antidepressant trials.

Chevance A, Naudet F, Gaillard R, Ravaud P, Porcher R.

Int J Methods Psychiatr Res. 2019 Sep;28(3):e1779. doi: 10.1002/mpr.1779. Epub 2019 Apr 17.

18.

Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions.

Iudici M, Riveros C, Gabay C, Puéchal X, Berthelot JM, Ravaud P.

Semin Arthritis Rheum. 2019 Mar 16. pii: S0049-0172(19)30003-4. doi: 10.1016/j.semarthrit.2019.03.009. [Epub ahead of print]

PMID:
30975475
19.
20.

The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses.

Atal I, Porcher R, Boutron I, Ravaud P.

J Clin Epidemiol. 2019 Jul;111:32-40. doi: 10.1016/j.jclinepi.2019.03.012. Epub 2019 Mar 30.

PMID:
30940600
21.

A scoping review provided a framework for new ways of doing research through mobilizing collective intelligence.

Nguyen VT, Benchoufi M, Young B, Ghosn L, Ravaud P, Boutron I.

J Clin Epidemiol. 2019 Jun;110:1-11. doi: 10.1016/j.jclinepi.2019.02.007. Epub 2019 Feb 14. Review.

22.

Time-dependent biases in observational studies of comparative effectiveness research in rheumatology. A methodological review.

Iudici M, Porcher R, Riveros C, Ravaud P.

Ann Rheum Dis. 2019 Apr;78(4):562-569. doi: 10.1136/annrheumdis-2018-214544. Epub 2019 Feb 12.

PMID:
30755417
23.

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.

Gottenberg JE, Morel J, Perrodeau E, Bardin T, Combe B, Dougados M, Flipo RM, Saraux A, Schaeverbeke T, Sibilia J, Soubrier M, Vittecoq O, Baron G, Constantin A, Ravaud P, Mariette X; French Society of Rheumatology and the investigators participating in AIR, ORA, and REGATE registries.

BMJ. 2019 Jan 24;364:l67. doi: 10.1136/bmj.l67.

24.

Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota.

Bafeta A, Koh M, Riveros C, Ravaud P.

Ann Intern Med. 2019 Jan 15;170(2):143-144. doi: 10.7326/L18-0562. No abstract available.

PMID:
30641574
25.

Living network meta-analysis was feasible when considering the pace of evidence generation.

Créquit P, Martin-Montoya T, Attiche N, Trinquart L, Vivot A, Ravaud P.

J Clin Epidemiol. 2019 Apr;108:10-16. doi: 10.1016/j.jclinepi.2018.12.008. Epub 2018 Dec 12.

PMID:
30552957
26.

Acceptable medication non-adherence: A crowdsourcing study among French physicians for commonly prescribed medications.

Sidorkiewicz S, Tran VT, Ravaud P.

PLoS One. 2018 Dec 13;13(12):e0209023. doi: 10.1371/journal.pone.0209023. eCollection 2018.

27.

Variation in severe postpartum hemorrhage management: A national vignette-based study.

Rousseau A, Rozenberg P, Perrodeau E, Ravaud P.

PLoS One. 2018 Dec 13;13(12):e0209074. doi: 10.1371/journal.pone.0209074. eCollection 2018.

28.

Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analyses.

Lerner I, Créquit P, Ravaud P, Atal I.

J Clin Epidemiol. 2019 Apr;108:86-94. doi: 10.1016/j.jclinepi.2018.12.001. Epub 2018 Dec 7.

PMID:
30528791
29.

Closing the Gap between Diagnostic Test Accuracy Reviews and Reporting Guidelines: The PRISMA-Diagnostic Test Accuracy Statement.

Chaimani A, Ravaud P.

Clin Chem. 2019 Feb;65(2):222-224. doi: 10.1373/clinchem.2018.296749. Epub 2018 Nov 30. No abstract available.

PMID:
30504260
30.

Ten years of interventional research in systemic sclerosis: a systematic mapping of trial registries.

Iudici M, Bafeta A, Atal I, Ravaud P.

Arthritis Care Res (Hoboken). 2018 Nov 26. doi: 10.1002/acr.23817. [Epub ahead of print]

PMID:
30474928
31.

Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data.

Kwakkenbos L, Juszczak E, Hemkens LG, Sampson M, Fröbert O, Relton C, Gale C, Zwarenstein M, Langan SM, Moher D, Boutron I, Ravaud P, Campbell MK, Mc Cord KA, van Staa TP, Thabane L, Uher R, Verkooijen HM, Benchimol EI, Erlinge D, Sauvé M, Torgerson D, Thombs BD.

Res Integr Peer Rev. 2018 Oct 29;3:9. doi: 10.1186/s41073-018-0053-3. eCollection 2018.

32.

Designs of trials assessing interventions to improve the peer review process: a vignette-based survey.

Heim A, Ravaud P, Baron G, Boutron I.

BMC Med. 2018 Oct 15;16(1):191. doi: 10.1186/s12916-018-1167-7.

33.

Digital diabetes: Perspectives for diabetes prevention, management and research.

Fagherazzi G, Ravaud P.

Diabetes Metab. 2019 Sep;45(4):322-329. doi: 10.1016/j.diabet.2018.08.012. Epub 2018 Sep 19. Review.

PMID:
30243616
34.

Making protocols available with the article improved evaluation of selective outcome reporting.

Calméjane L, Dechartres A, Tran VT, Ravaud P.

J Clin Epidemiol. 2018 Dec;104:95-102. doi: 10.1016/j.jclinepi.2018.08.020. Epub 2018 Sep 6. Review.

PMID:
30196127
35.

Association Between Publication Characteristics and Treatment Effect Estimates: A Meta-epidemiologic Study.

Dechartres A, Atal I, Riveros C, Meerpohl J, Ravaud P.

Ann Intern Med. 2018 Sep 18;169(6):385-393. doi: 10.7326/M18-1517. Epub 2018 Aug 21.

PMID:
30140933
36.

Correction to: Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys.

Biggane AM, Brading L, Ravaud P, Young B, Williamson PR.

Trials. 2018 Aug 8;19(1):430. doi: 10.1186/s13063-018-2595-6.

37.

Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data.

Kwakkenbos L, Imran M, McCord KA, Sampson M, Fröbert O, Gale C, Hemkens LG, Langan SM, Moher D, Relton C, Zwarenstein M, Benchimol EI, Boutron I, Campbell MK, Erlinge D, Jawad S, Ravaud P, Rice DB, Sauve M, van Staa TP, Thabane L, Uher R, Verkooijen HM, Juszczak E, Thombs BD.

BMJ Open. 2018 Aug 5;8(8):e025266. doi: 10.1136/bmjopen-2018-025266.

38.

Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota: A Systematic Review.

Bafeta A, Koh M, Riveros C, Ravaud P.

Ann Intern Med. 2018 Aug 21;169(4):240-247. doi: 10.7326/M18-0343. Epub 2018 Jul 17.

PMID:
30014150
39.

Avoidable waste of research related to outcome planning and reporting in clinical trials.

Yordanov Y, Dechartres A, Atal I, Tran VT, Boutron I, Crequit P, Ravaud P.

BMC Med. 2018 Jun 11;16(1):87. doi: 10.1186/s12916-018-1083-x.

40.

Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis.

Rivière E, Sellam J, Pascaud J, Ravaud P, Gottenberg JE, Mariette X.

Arthritis Res Ther. 2018 Jun 8;20(1):122. doi: 10.1186/s13075-018-1628-6.

41.

Mapping of Crowdsourcing in Health: Systematic Review.

Créquit P, Mansouri G, Benchoufi M, Vivot A, Ravaud P.

J Med Internet Res. 2018 May 15;20(5):e187. doi: 10.2196/jmir.9330.

42.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. Epub 2018 May 3.

PMID:
29724729
43.

Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.

Puéchal X, Iudici M, Calich AL, Vivot A, Terrier B, Régent A, Cohen P, Jeunne CL, Mouthon L, Ravaud P, Guillevin L.

Rheumatology (Oxford). 2019 Mar 1;58(3):401-409. doi: 10.1093/rheumatology/key117.

PMID:
29722877
44.

Patients' perspectives on how to decrease the burden of treatment: a qualitative study of HIV care in sub-Saharan Africa.

Tran VT, Messou E, Mama Djima M, Ravaud P, Ekouevi DK.

BMJ Qual Saf. 2019 Apr;28(4):266-275. doi: 10.1136/bmjqs-2017-007564. Epub 2018 Apr 29.

45.

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25. Erratum in: Ann Rheum Dis. 2019 Sep;78(9):e101.

PMID:
29695500
46.

Patient-important outcomes in systematic reviews: Poor quality of evidence.

Yordanov Y, Dechartres A, Ravaud P.

PLoS One. 2018 Apr 5;13(4):e0195460. doi: 10.1371/journal.pone.0195460. eCollection 2018.

47.

Misrepresentation and distortion of research in biomedical literature.

Boutron I, Ravaud P.

Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2613-2619. doi: 10.1073/pnas.1710755115.

48.

Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy.

Freund R, Granger B, Francois C, Carcelain G, Ravaud P, Mariette X, Fautrel B.

Presse Med. 2018 Feb;47(2):e9-e13. doi: 10.1016/j.lpm.2017.09.029. Epub 2018 Feb 23.

PMID:
29478790
49.

Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys.

Biggane AM, Brading L, Ravaud P, Young B, Williamson PR.

Trials. 2018 Feb 17;19(1):113. doi: 10.1186/s13063-018-2493-y. Erratum in: Trials. 2018 Aug 8;19(1):430.

50.

Factors associated with online media attention to research: a cohort study of articles evaluating cancer treatments.

Haneef R, Ravaud P, Baron G, Ghosn L, Boutron I.

Res Integr Peer Rev. 2017 Jul 1;2:9. doi: 10.1186/s41073-017-0033-z. eCollection 2017.

Supplemental Content

Loading ...
Support Center